This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Celltrion Inc., Korea Disease Control and Prevention Agency. Active years: 2026.
Company Filing History:
1 out of 35 
1 out of 1 Years Active: 2026
Title: Hye-Min Woo: Innovator in SARS-CoV-2 Neutralization
Introduction
Hye-Min Woo is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections.
Latest Patents
Hye-Min Woo holds a patent for a binding molecule that exhibits neutralizing activity against SARS-coronavirus-2 (SARS-CoV-2). This invention relates to a binding molecule that effectively binds to the spike protein (S protein) on the surface of SARS-coronavirus-2. The binding molecule demonstrates a strong ability to neutralize SARS-CoV-2, making it highly valuable for the diagnosis, prevention, or treatment of COVID-19.
Career Highlights
Throughout his career, Hye-Min Woo has worked with prominent organizations such as Celltrion Inc. and the Korea Disease Control and Prevention Agency. His work in these institutions has allowed him to contribute to significant advancements in public health and biotechnology.
Collaborations
Hye-Min Woo has collaborated with talented individuals in his field, including Ji-Min Seo and Soo-Young Lee. These partnerships have fostered innovation and progress in their shared research endeavors.
Conclusion
Hye-Min Woo's contributions to the development of neutralizing agents against SARS-CoV-2 highlight his importance as an inventor in the biotechnology sector. His work continues to play a crucial role in addressing global health challenges.